Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Drug Nomenclature01:17

Drug Nomenclature

1.7K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Drug Regulation01:25

Drug Regulation

1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Absorption: Overview01:17

Drug Absorption: Overview

580
The process of drug absorption signifies the transition of a drug from its site of administration into the plasma. This process is influenced by various factors, including the route of administration, the anatomy of the absorption site, the mechanism of absorption, gut motility, and the drug's physicochemical properties.
When drugs are injected intravenously, they directly enter the systemic circulation. Alternatively, orally administered drugs navigate through the gastrointestinal (GI)...
580
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rare tumors: a blue ocean of investigation.

Frontiers of medicine·2023
Same author

Treatment of primary cutaneous lichenoid amyloidosis with abrocitinib: A pilot study in two cases.

International journal of dermatology·2023
Same author

Adverse events of PD-(L)1 inhibitors plus anti-VEGF(R) agents compared with PD-(L)1 inhibitors alone for cancer patients: a systematic review and meta-analysis.

Frontiers in pharmacology·2023
Same author

CircHIPK2 facilitates phenotypic switching of vascular smooth muscle cells in hypertension.

Journal of human hypertension·2023
Same author

Clinical Features and Skin Microbiome of Tinea Scrotum: An Observational Study of 113 Cases in China.

Mycopathologia·2023
Same author

CRISPR-Cas12a base editors confer efficient multiplexed genome editing in rice.

Plant communications·2023
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026
Same journal

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Drug discovery today·2026
Same journal

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

Drug discovery today·2026
Same journal

A20 as a novel immunoregulatory target for neuroinflammation.

Drug discovery today·2026
See all related articles

Related Experiment Video

Updated: Jun 26, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

547

Text summarization with ChatGPT for drug labeling documents.

Lan Ying1, Zhichao Liu2, Hong Fang1

  • 1FDA National Center for Toxicological Research, Jefferson, AR 72079, USA.

Drug Discovery Today
|May 9, 2024
PubMed
Summary
This summary is machine-generated.

Large language models like ChatGPT can automate scientific text summarization. ChatGPT summaries closely match human experts, especially for drug safety information, accelerating critical research areas.

Keywords:
ChatGPTartificial intelligence (AI)document summarizationdrug informationdrug safetylarge language models (LLMs)natural language processing (NLP)text summarization

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.6K

Related Experiment Videos

Last Updated: Jun 26, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

547
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.6K

Area of Science:

  • Biomedical Informatics
  • Computational Linguistics
  • Pharmacology

Background:

  • Text summarization is vital for scientific research, drug discovery, and regulatory processes.
  • This task requires significant domain expertise and advanced language skills.
  • Large language models (LLMs) present new opportunities for automating summarization.

Purpose of the Study:

  • To evaluate the summarization capabilities of ChatGPT against human experts.
  • To assess the performance of ChatGPT using FDA drug labeling documents as a benchmark.
  • To determine the potential of LLMs in scientific text summarization.

Main Methods:

  • Comparison of ChatGPT-generated summaries with human-generated summaries.
  • Utilized over 14,000 FDA drug labeling documents for analysis.
  • Focused on key labeling sections and drug safety information.

Main Results:

  • ChatGPT-generated summaries demonstrated high similarity to human expert summaries.
  • ChatGPT showed even greater accuracy in summarizing drug safety information.
  • The findings validate LLMs as effective tools for scientific summarization.

Conclusions:

  • ChatGPT shows significant potential for automating text summarization in scientific domains.
  • The technology can accelerate critical processes, particularly in drug safety analysis.
  • LLMs offer a promising avenue for enhancing efficiency in research and development.